Literature DB >> 16423044

Interleukin-16 inhibits interleukin-13 production by allergen-stimulated blood mononuclear cells.

Souad El Bassam1, Stéphane Pinsonneault, Hardy Kornfeld, Fucheng Ren, José Menezes, Sophie Laberge.   

Abstract

Expression of interleukin (IL)-16 is increased in bronchial mucosal biopsies of atopic asthmatics compared to normal controls. The functional significance of increased expression of IL-16 at sites of allergic inflammation is not yet clear. We have previously shown that IL-16 inhibits IL-5 secretion by allergen-stimulated peripheral blood mononuclear cells (PBMC). We investigated whether IL-16 inhibits the production of other T helper 2 cytokines, namely IL-13 and IL-4, by allergen-specific T cells. PBMC from ragweed-sensitive atopic subjects were stimulated with allergen extract for cytokine production in the presence or absence of rhIL-16. Production of cytokines was assessed by enzyme-linked immunosorbent assay and reverse transcription-polymerase chain reaction. To evaluate whether the modulatory effect of IL-16 on cytokine synthesis was mediated by interferon-gamma (IFN-gamma), IL-10, IL-12 or IL-18, allergen-stimulated PBMC were cultured in presence of IL-16 and neutralizing concentrations of relevant antibodies. Allergen-stimulated PBMC produced significantly elevated levels of IL-13 (90-740 pg/ml) as compared to unstimulated PBMC (0-375 pg/ml, P < 0.01). Addition of rhIL-16 resulted in down-regulation of IL-13 mRNA expression as well as significantly reduced amounts of IL-13 released by allergen-stimulated PBMC (0-457 pg/ml, P < 0.001), as observed for IL-5. No effect of IL-16 was observed on IL-4 mRNA expression. Treatment with IL-16 resulted in increased levels of IL-10 and IL-18 in allergen-stimulated cell culture. Neutralization of IFN-gamma, IL-12, IL-10 or IL-18 did not alter the inhibitory effects of IL-16 on IL-13 and IL-5 secretion by allergen-stimulated PBMC. IL-16 did not modify IL-13 synthesis by anti-CD3-stimulated CD4(+) T cells, but it significantly reduced the production of IL-5. These data suggest that IL-16 may play an important immunoregulatory role in allergic states in response to allergen.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16423044      PMCID: PMC1782191          DOI: 10.1111/j.1365-2567.2005.02269.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  31 in total

1.  Effect of interleukin-16-blocking peptide on parameters of allergic asthma in a murine model.

Authors:  J J de Bie; P A Henricks; W W Cruikshank; G Hofman; F P Nijkamp; A J van Oosterhout
Journal:  Eur J Pharmacol       Date:  1999-10-27       Impact factor: 4.432

2.  A role for IL-16 in the cross-talk between dendritic cells and T cells.

Authors:  A Kaser; S Dunzendorfer; F A Offner; T Ryan; A Schwabegger; W W Cruikshank; C J Wiedermann; H Tilg
Journal:  J Immunol       Date:  1999-09-15       Impact factor: 5.422

3.  Increased expression of IL-16 immunoreactivity in bronchial mucosa after segmental allergen challenge in patients with asthma.

Authors:  S Laberge; S Pinsonneault; E M Varga; S J Till; K Nouri-Aria; M Jacobson; W W Cruikshank; D M Center; Q Hamid; S R Durham
Journal:  J Allergy Clin Immunol       Date:  2000-08       Impact factor: 10.793

Review 4.  Interleukin 16: implications for CD4 functions and HIV-1 progression.

Authors:  D M Center; H Kornfeld; T C Ryan; W W Cruikshank
Journal:  Immunol Today       Date:  2000-06

5.  IL-16 inhibits IL-5 production by antigen-stimulated T cells in atopic subjects.

Authors:  S Pinsonneault; S El Bassam; B Mazer; W W Cruikshank; S Laberge
Journal:  J Allergy Clin Immunol       Date:  2001-03       Impact factor: 10.793

6.  Interleukin-16 stimulates the expression and production of pro-inflammatory cytokines by human monocytes.

Authors:  N L Mathy; W Scheuer; M Lanzendörfer; K Honold; D Ambrosius; S Norley; R Kurth
Journal:  Immunology       Date:  2000-05       Impact factor: 7.397

7.  IL-4, IL-13, and dexamethasone augment fibroblast proliferation in asthma.

Authors:  M Kraft; C Lewis; D Pham; H W Chu
Journal:  J Allergy Clin Immunol       Date:  2001-04       Impact factor: 10.793

8.  IL-4 and IL-13 induce myofibroblastic phenotype of human lung fibroblasts through c-Jun NH2-terminal kinase-dependent pathway.

Authors:  S Hashimoto; Y Gon; I Takeshita; S Maruoka; T Horie
Journal:  J Allergy Clin Immunol       Date:  2001-06       Impact factor: 10.793

Review 9.  IL-12/IL-13 axis in allergic asthma.

Authors:  M Wills-Karp
Journal:  J Allergy Clin Immunol       Date:  2001-01       Impact factor: 10.793

10.  IL-16 promotes leukotriene C(4) and IL-4 release from human eosinophils via CD4- and autocrine CCR3-chemokine-mediated signaling.

Authors:  Christianne Bandeira-Melo; Kumiya Sugiyama; Lesley J Woods; Mojabeng Phoofolo; David M Center; William W Cruikshank; Peter F Weller
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

View more
  5 in total

1.  Interleukin-16 aggravates ovalbumin-induced allergic inflammation by enhancing Th2 and Th17 cytokine production in a mouse model.

Authors:  Chunxia Li; Jun Dai; Guanjun Dong; Qun Ma; Zhihua Li; Hui Zhang; Fenglian Yan; Junfeng Zhang; Bo Wang; Hui Shi; Yuzhen Zhu; Xiaoying Yao; Chuanping Si; Huabao Xiong
Journal:  Immunology       Date:  2019-07       Impact factor: 7.397

2.  Human mid-gestation amniotic fluid contains interleukin-16 bioactivity.

Authors:  Catherine A Thornton; Judith A Holloway; Janis K Shute; John W Holloway; Norma D Diaper; John O Warner
Journal:  Immunology       Date:  2009-04       Impact factor: 7.397

3.  Integrative omics approach identifies interleukin-16 as a biomarker of emphysema.

Authors:  Russell P Bowler; Timothy M Bahr; Grant Hughes; Sharon Lutz; Yu-Il Kim; Christopher D Coldren; Nichole Reisdorph; Katerina J Kechris
Journal:  OMICS       Date:  2013-10-19

Review 4.  Ragweed-induced allergic rhinoconjunctivitis: current and emerging treatment options.

Authors:  Friedrich Ihler; Martin Canis
Journal:  J Asthma Allergy       Date:  2015-02-16

5.  In vitro allergen challenge of peripheral blood induces differential gene expression in mononuclear cells of asthmatic patients: inhibition of cytosolic phospholipase A2alpha overcomes the asthma-associated response.

Authors:  K A Whalen; H Legault; C Hang; A Hill; M Kasaian; D Donaldson; G W Bensch; G Bensch; J Baker; P S Reddy; N Wood; M K Ramarao; D K Ellis; C Csimma; C McKee; J D Clark; J Ryan; A J Dorner; M O'Toole
Journal:  Clin Exp Allergy       Date:  2008-07-28       Impact factor: 5.018

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.